Vous voulez voir cette page en français ? Cliquez ici.


or
Sign in to turn on 1-Click ordering.
More Buying Choices
Have one to sell? Sell yours here
From Alchemy to Ipo: The Business Of Biotechnology
 
See larger image 
Share your own customer images
Publisher: learn how customers can search inside this book.

From Alchemy to Ipo: The Business Of Biotechnology [Paperback]

Cynthia Robbins-roth (Author)
4.2 out of 5 stars  See all reviews (21 customer reviews)
List Price: CDN$ 21.00
Price: CDN$ 15.33 & eligible for FREE Super Saver Shipping on orders over CDN$ 25. Details
You Save: CDN$ 5.67 (27%)
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
Usually ships within 1 to 3 weeks.
Ships from and sold by Amazon.ca. Gift-wrap available.

Formats

 Amazon Price New from Used from
Hardcover --   -- --
Paperback CDN $15.33   -- --

Product Details

Product Description

From Amazon

Despite unnerving swings in individual stock valuations--or perhaps because of them--many knowledgeable observers still believe the 21st century will ultimately earn its stripes as the Age of Biotech. Cynthia Robbins-Roth, named by Forbes magazine as one of the industry's top insiders, certainly is among them. And in From Alchemy to IPO, she persuasively argues investors better take heed because they ain't seen nothin' yet. "Most of us think of biotech as medicine or genetically engineered crops," writes Robbins-Roth. But in the very near future, she continues, it also "may make it possible for humans to reach the stars and to change the environment on other planets." Think that's far-fetched? She says developments like this are already in early stages and, in a deliberately proselytizing manner, traces their roots to the current business nitty-gritty, finally focusing on the long-term moneymaking potential. "The biotech world will never be an easy place for investors," she cautions, but with hundreds of ongoing projects "poised to power into the marketplace," there will be plenty of "opportunities for investors and employees alike." Recommended for readers seeking an informed tutorial on this field of the future. --Howard Rothman --This text refers to an out of print or unavailable edition of this title.

Review

"A fascinating glimpse inside the life-and-death business of biotechnology. A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth." -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers "From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can." -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen"
See all Product Description

Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 
See most popular tags
 

Customer Reviews

21 Reviews
5 star:
 (12)
4 star:
 (5)
3 star:
 (1)
2 star:
 (2)
1 star:
 (1)
 
 
 
 
 
Average Customer Review
4.2 out of 5 stars (21 customer reviews)
 
 
 
 
Share your thoughts with other customers:
Most helpful customer reviews

4.0 out of 5 stars Brilliant Overview, May 31 2004
By 
Rebecca Fett (Sydney, Australia) - See all my reviews
This review is from: From Alchemy to Ipo: The Business of Biotechnology (Hardcover)
This is a great overview of the world of biotech. The author explains the science with clarity and enthusiasm and the introduction this book provides to the corporate side of biotech is also very interesting and well written.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


2.0 out of 5 stars bad writing, Jan 14 2004
By 
Jason Ryan (West Hartford, CT) - See all my reviews
(REAL NAME)   
This review is from: From Alchemy to Ipo: The Business Of Biotechnology (Paperback)
I read the first 20 pages of this book and quit. It was too painful to keep going. The author's wording in convoluted, tangential, and just plain annoying. She throws out dozens of names from the industry, so many you can't keep them straight. There is poor flow to the writing, so you cannot understand why she is telling you things from one line to the next. The topics of each paragraph jump from one subject to another with abrupt, confusing transitions. I returned the book!
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


5.0 out of 5 stars Clear and non hyped intro into biotech, May 27 2002
This review is from: From Alchemy to Ipo: The Business Of Biotechnology (Paperback)
I'll be starting a biomedical engineering Ph.D. program in the fall and have read recently a few books on the biotech subject. This one gave the clearest picture of the biotech industries, the companies in them, how to manage and finance them, as well as how to recognize solid biotech companies for investing purposes. A quick and entertaining read for anyone interested in the business behind biotechnology.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No

Share your thoughts with other customers: Create your own review
Want to see more reviews on this item?
› Go to Amazon.com to see all 24 reviews  4.3 out of 5 stars 
 
 		 Most recent customer reviews











Only search this product's reviews


Listmania!

Create a Listmania! list

Look for similar items by category

Look for similar items by subject























i.e., each book must be in subject 1 AND subject 2 AND ...

Feedback

Would you like to update product info or give feedback on images?

Amazon.ca Privacy Statement Amazon.ca Shipping Information Amazon.ca Returns & Exchanges